You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

wet AMD

Showing 1 - 25 of 1,138
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

OCT Angiography in Wet AMD

Recruiting
  • Neovascular (Wet) Age-related Macular Degeneration (AMD)
  • Optical Coherence Tomography
  • Portland, Oregon
    Casey Eye Institute, Oregon Health & Science University
Sep 20, 2022

s in Wet AMD in Active Smokers

Completed
  • Wet Age-related Macular Degeneration
  • Medical Data extraction
  • Brussels, Belgium
    CHU Brugmann
Mar 7, 2022

Neovascular Age-related Macular Degeneration Trial (FT-003)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • FT-003
  • (no location specified)
Nov 21, 2022

Following Intensive Anti-VEGF Therapy in Wet AMD

Completed
  • Age-Related Macular Degeneration
  • Budapest, Hungary
  • +1 more
Dec 28, 2022

Wet Age-related Macular Degeneration Trial in Boston, Worcester (Intravitreal anti-VEGF, Intravitreal AAVCAGsCD59, Oral

Completed
  • Wet Age-related Macular Degeneration
  • Intravitreal anti-VEGF
  • +2 more
  • Boston, Massachusetts
  • +1 more
May 24, 2022

Reading Speed Improvements in Wet-AMD Patients After Ranibizumab

Completed
  • Ophthalmopathy
  • Wet Macular Degeneration
    • (no location specified)
    Jul 20, 2021

    Wet Age-related Macular Degeneration Trial in Bern (Aflibercept, Brolucizumab, early treat and extend (T&E))

    Enrolling by invitation
    • Wet Age-related Macular Degeneration
    • Bern, Switzerland
      Berner Augenklinik am Lindenhofspital
    May 13, 2022

    Wet Age-related Macular Degeneration Trial in Beijing, Wuhan, Shanghai (CMAB818, Lucentis®)

    Recruiting
    • Wet Age-related Macular Degeneration
    • Beijing, Beijing, China
    • +3 more
    Jun 14, 2022

    Exudative Macular Degeneration, Wet Age-related Macular Degeneration Trial in Iowa City (Doxycycline Hyclate, Placebo)

    Recruiting
    • Exudative Macular Degeneration
    • Wet Age-related Macular Degeneration
    • Doxycycline Hyclate
    • Placebo
    • Iowa City, Iowa
      University of Iowa Hospitals & Clinics Department of Ophthalmolo
    Apr 5, 2022

    Wet Age-related Macular Degeneration Trial in United States (Eyp-1901, Aflibercept 2Mg/0.05Ml Inj,Oph)

    Recruiting
    • Wet Age-related Macular Degeneration
    • Melbourne, Florida
    • +4 more
    Aug 18, 2022

    Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT]

    Enrolling by invitation
    • Wet Age-related Macular Degeneration
    • Neovascular Age-related Macular Degeneration
    • ADVM-022
    • Bakersfield, California
    • +8 more
    Dec 23, 2021

    Macular Degeneration, Wet, Metamorphopsia Trial

    Recruiting
    • Macular Degeneration, Wet
    • Metamorphopsia
      • Cuneo, Piedmont, Italy
        Ospedale Santa Croce
      Sep 20, 2022

      CNV in AMD Analyzed by OCT Angiography Under IntravitreaL Eylea

      Active, not recruiting
      • AMD
      • Exudative Macular Degeneration
        • Bordeaux, France
        • +4 more
        Dec 2, 2022

        Macular Degeneration, Choroidal Neovascularization Trial in 'Aiea, Oak Forest (episcleral brachytherapy)

        Recruiting
        • Macular Degeneration, Choroidal Neovascularization
        • episcleral brachytherapy
        • 'Aiea, Hawaii
        • +1 more
        Feb 11, 2022

        Wet Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration Trial in United States (ADVM-022)

        Active, not recruiting
        • Wet Age-related Macular Degeneration
        • Neovascular Age-related Macular Degeneration
        • ADVM-022
        • Bakersfield, California
        • +10 more
        Mar 21, 2022

        Neovascular Age-related Macular Degeneration

        Completed
        • Age-related Macular Degeneration (AMD)
        • East Hanover, New Jersey
          Novartis Investigative Site
        Dec 15, 2021

        Wet Age-related Macular Degeneration Trial in United States (EYP-1901)

        Completed
        • Wet Age-related Macular Degeneration
        • Phoenix, Arizona
        • +10 more
        Jul 25, 2022

        Ocular Adverse Events in Neovascular Agerelated Macular

        Completed
        • Age-related Macular Degeneration (AMD)
        • Aflibercept
        • +2 more
        • East Hanover, New Jersey
          Novartis Investigative Site
        Dec 15, 2021

        Retinal Revascularization and Clinical Indicators of Neovascular

        Recruiting
        • Wet Macular Degeneration
        • Ophthalmic Drugs
        • Arendal, Agder, Norway
          Sorlandet Hospital HF
        Mar 3, 2022

        Ocular Adverse Events in Neovascular Age-related Macular

        Completed
        • Age-related Macular Degeneration (AMD)
        • Aflibercept
        • +2 more
        • East Hanover, New Jersey
          Novartis Investigative Site
        Dec 15, 2021

        Neovascular Age-related Macular Degeneration

        Completed
        • Age-related Macular Degeneration (AMD)
        • East Hanover, New Jersey
          Novartis Pharmaceuticals
        Oct 19, 2021

        Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in San Antonio (D-4517.2)

        Recruiting
        • Neovascular Age-related Macular Degeneration
        • Diabetic Macular Edema
        • Los Angeles, California
        • +11 more
        Jan 11, 2023

        Wet Macular Degeneration Trial in Portugal, Spain (Retilut, Theavit)

        Completed
        • Wet Macular Degeneration
        • Retilut
        • Theavit
        • Celas, Coimbra, Portugal
        • +8 more
        Feb 11, 2021

        Wet Macular Degeneration, Neovascular Age-related Macular Degeneration, Macular Degeneration Trial in Czechia, Poland, Slovakia

        Recruiting
        • Wet Macular Degeneration
        • +2 more
        • Brno, Czechia
        • +15 more
        Jan 25, 2023

        RGX-314 Administered in the Suprachoroidal Space for nAMD

        Enrolling by invitation
        • Neovascular Age-Related Macular Degeneration (nAMD)
        • +5 more
        • No intervention.
        • Phoenix, Arizona
        • +14 more
        Jan 14, 2022